**Alto Neuroscience (NYSE:ANRO) Enters into Amended Loan Agreement with K2 HealthVentures LLC**Alto Neuroscience, Inc. (ANRO) recently disclosed its current report, Form 8-K filing to the Securities and Exchange Commission. The filing, dated January
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Alto Neuroscience’s...
Gladstone Investment Announces Monthly Cash Distributions for 2025 and Earnings Report Date
Gladstone Investment Corporation recently declared monthly cash distributions for their common stock and unveiled the upcoming earnings release date for the third fiscal quarter. On...
Kymera Therapeutics (NASDAQ:KYMR) Provides Business Update and Preliminary Cash Balance for 2024
Kymera Therapeutics, Inc., a leader in targeted protein degradation, recently released its preliminary cash balance for December 31, 2024, along with a business update outlining...
Jeff Bezos’ Blue Origin launches massive New Glenn rocket on first test flight and reaches orbit
By MARCIA DUNN, Associated Press Aerospace Writer CAPE CANAVERAL, Fla. (AP) — Blue Origin launched its massive new rocket on its first test flight Thursday,...
Jeff Bezos’ Blue Origin launches massive New Glenn rocket on first test flight and reaches orbit
By MARCIA DUNN, Associated Press Aerospace Writer CAPE CANAVERAL, Fla. (AP) — Blue Origin launched its massive new rocket on its first test flight Thursday,...
Reading, Arlington battle to a draw in a ML boys hockey showdown
READING – The last time the Reading and Arlington boys hockey teams matched up, the Spy Ponders’ heroics in overtime stole the Middlesex League Liberty...